Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2005
10/26/2005CN1224354C Preparation method for health food compounded by Asparagus sprengreri, ginseng fibrous root, lily bulb and officinal dendrobium stem
10/26/2005CN1224345C Preparation method for health food compounded by asparagus sprengreri, radix rehmanniae preparata, ginseng fibrous root, officinal dendrobium stem and royal jelly
10/25/2005US6958705 Microprocessor controlled ambulatory medical apparatus with hand held communication device
10/25/2005US6958572 Controlled non-normal alignment of catalytically grown nanostructures in a large-scale synthesis process
10/25/2005US6958319 Stability and longer shelf life; bortezomib N-(2-pyrazine)carbonyl-L-phenylalanine-L-leucine boronic acid
10/25/2005US6958241 Liposomes with outer surfaces having an affinity moiety that binds to a biological therapy target surface, and a hydrophilic polymer coating reversibly conjugated to said moiety; e.g. polymyxin B conjugate liposome for septic shock
10/25/2005US6958161 Stable, in release profile after storage of a preparation
10/25/2005US6958160 liposomes include diacylglycerol-PEG compounds; melting point below about 40 degrees C, and acyl chains greater than or equal to 14 carbons in length; use in drug delivery, diagnostics, cosmetics, cosmeceuticals and nutraceuticals
10/25/2005US6958159 Pharmaceutical gel composition
10/25/2005US6958158 Immune modulation device for use in animals
10/25/2005US6958156 Bioavailability, solubility; dietetic adjuvant, foods, cosmetics
10/25/2005US6958154 Tacky component of an adhesive, and a film-forming, non-tacky component that are immiscible with each other to undergo phase separation
10/25/2005US6958153 topical formulation of azithromycin / clarithromycin macrocyclic lactone antibiotic or Tacrolimus/ Sirolimus immunosuppressive macrolide and permeation modulator; minimizes systemic exposure treating at site reduced side effects; scalp conditions
10/25/2005US6958148 microparticle comprising active agent and polymer having transglutaminase substrate reactive groups, wherein reactive groups are surface available, and polymer comprises amino acids having at least three contiguous linked glutamines; drug delivery
10/25/2005US6958143 Aftersmoking; converting nicotine to cotinine; discharing in urine
10/25/2005US6958142 Nasal spray formulation and method
10/25/2005CA2329172C Storage stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
10/25/2005CA2298238C Controlled release by extrusion of solid amorphous dispersions of drugs
10/25/2005CA2273921C Medical adhesive device dispenser and method
10/25/2005CA2227887C Pharmaceutical compositions of conjugated estrogens and methods for their use
10/25/2005CA2198195C Container with freeze-dried vaccine components
10/25/2005CA2198092C Transdermal therapeutic system with protection against hydrolysis
10/25/2005CA2197865C Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives
10/25/2005CA2144441C Dexpanthenol-containing plaster for the transdermal application of steroid hormones
10/20/2005WO2005098429A2 System and method for real-time diagnosis, treatment, and therapeutic drug monitoring
10/20/2005WO2005098426A1 Skin sensitivity test device and method
10/20/2005WO2005097871A1 Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same
10/20/2005WO2005097677A1 Embolization
10/20/2005WO2005097672A2 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy
10/20/2005WO2005097228A2 Coating compositions for bioactive agents
10/20/2005WO2005097225A1 New viscoelastic composition, method of use and package
10/20/2005WO2005097216A1 Compositions containing copper salts and soy products
10/20/2005WO2005097198A1 Preparation for oral administration
10/20/2005WO2005097197A1 Polymer particles containing active agents
10/20/2005WO2005097196A2 Pharmaceutical preparation containing drospirenone for application to the skin
10/20/2005WO2005097195A2 Methods of reducing aggregation of il-1ra
10/20/2005WO2005097194A1 Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof
10/20/2005WO2005097159A1 Ophthalmic preparation containing glycoprotein
10/20/2005WO2005097157A1 Ophthalmic preparation containing glycomacropeptide
10/20/2005WO2005097152A1 Turmeric extract-containing composition having improved caking capacity
10/20/2005WO2005097148A1 Pharmaceutics of traditional chinese medicine of treating aids and preparation method thereof
10/20/2005WO2005097144A1 Composition for cleaning intestinal canal
10/20/2005WO2005097120A1 Compositions with reduced hepatotoxicity
10/20/2005WO2005097105A1 Injectable composition for the treatment of cancers
10/20/2005WO2005097104A1 SOLID PHARMACEUTICAL PREPARATION CONTAINING DIBENZ[b,e]OXEPINE DERIVATIVE
10/20/2005WO2005097102A2 Method to treat chronic heart failure and/or elevated cholesterol levels
10/20/2005WO2005097091A1 Composition comprising reduced-form coenzyme q10 and carotenoid compound
10/20/2005WO2005097085A1 Nutrient system for individualized responsive dosing regimens
10/20/2005WO2005097083A2 Transdermal administration of proton pump inhibitors
10/20/2005WO2005097082A1 Enteric coatings for orally ingestible substrates
10/20/2005WO2005097081A1 Ion binding polymers and uses thereof
10/20/2005WO2005097080A1 Preparation for oral administration
10/20/2005WO2005097079A2 Controlled release dosage for gaba receptor agonist
10/20/2005WO2005097078A1 Compressed composition comprising magnesium salt
10/20/2005WO2005097077A2 Spray dried pharmaceutical compositions
10/20/2005WO2005097076A2 Low dose pharmaceutical products
10/20/2005WO2005097075A2 Tamper resistant dosage form comprising an adsorbent and an adverse agent
10/20/2005WO2005097074A1 Microparticles for cell delivery
10/20/2005WO2005097073A1 Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases
10/20/2005WO2005097072A1 Ion binding compositions
10/20/2005WO2005097071A2 Manufacture of strong, lightweight carrier granules
10/20/2005WO2005097070A1 Solid pharmaceutical preparation with improved stability and process for producing the same
10/20/2005WO2005097069A1 Topical skin protectant cosmetic compositions
10/20/2005WO2005097068A1 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
10/20/2005WO2005097067A1 Zinc preservative composition and method of use
10/20/2005WO2005097066A2 Controlled delivery of therapeutic agents from medical articles
10/20/2005WO2005097065A1 Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease
10/20/2005WO2005097064A2 Taste-masked drugs in rupturing multiparticulates
10/20/2005WO2005097063A2 Natamycin dosage form, process for preparing same, method for preserving a food product and preserved food product
10/20/2005WO2005097062A1 deferasirox DISPERSIBLE TABLETS
10/20/2005WO2005097061A1 Encapsulated peptide copper complexes and compositions and methods related thereto
10/20/2005WO2005097058A2 Cyclodextrin inclusions complexes of pyrimidine-2,4,6-triones
10/20/2005WO2005097041A1 Nucleated molded article and method of producing the same
10/20/2005WO2005097021A1 Medical plaster for application on the skin
10/20/2005WO2005096989A1 Graft material and stent graft comprising extra collagen matrix and method of preparation
10/20/2005WO2005096717A2 Agent exhibiting hepatoprotective properties
10/20/2005WO2005084639A3 Polymeric drug delivery system for hydrophobic drugs
10/20/2005WO2005074887A3 Amphiphilic star-like or scorpion-like macromolecules, various compositions and uses thereof
10/20/2005WO2005072268A3 Treatment of degeneraative cartilage conditions in a mammal with glycosidase inhibitors
10/20/2005WO2005065664A8 Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
10/20/2005WO2005058472A3 Systems for preparing fine particles and other substances
10/20/2005WO2005053660A3 Pharmaceutical compositions comprising danazol
10/20/2005WO2005051362A3 Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
10/20/2005WO2005049886A3 Plasma thin-film deposition method
10/20/2005WO2005044985A3 Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections
10/20/2005WO2005025535A3 Methods for preparing pharmaceutical compositions
10/20/2005WO2005018530A3 Penetrating pharmaceutical foam
10/20/2005WO2005011638A3 Methods for the stabilization of atorvastatin
10/20/2005WO2004103266A8 Protein kinase c peptides for use in withdrawal
10/20/2005WO2004071398A9 Pharmaceutical patch
10/20/2005WO2004028504A8 Modified release dosage forms
10/20/2005WO2003002094A8 Enhanced pharmacokinetic profile of hydrophobic substances
10/20/2005US20050234432 Therapeutic treatment of disorders based on timing information
10/20/2005US20050234431 Intravascular delivery system for therapeutic agents
10/20/2005US20050234230 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/20/2005US20050234114 Encapsulated with macromolecules, bile salts
10/20/2005US20050234052 Treatment for ocular infections
10/20/2005US20050234028 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol
10/20/2005US20050234018 Drug delivery to the back of the eye
10/20/2005US20050234016 Process for the preparation of adsorbates of valsartan and/or its solvates or hydrates
1 ... 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 ... 2991